Transport of somatostatin and substance P by human P-glycoprotein

被引:4
作者
Uchiyama-Kokubu, N
Naito, M
Nakajima, M
Tsuruo, T
机构
[1] Novartis Pharma KK, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
[3] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Toshima Ku, Tokyo 1708455, Japan
关键词
P-glycoprotein; bioactive peptide; adenosine 5'-triphosphatase; transport;
D O I
10.1016/j.febslet.2004.07.084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-glycoprotein is an efflux pump for a broad spectrum of hydrophobic agents. We found that bioactive peptides including somatostatin and substance P inhibit ATP-dependent vincristine binding to P-glycoprotein-overexpressing K562/ADM membrane vesicles. Some of these bioactive peptides including somatostatin stimulate basal ATPase activity of P-glycoprotein; in contrast, other peptides including substance P inhibit it. The K562/ADM membrane vesicles showed an ATP-dependent, osmotically sensitive uptake of somatostatin and substance P, which was inhibited by valspodar, an inhibitor of P-glycoprotein. These findings suggested that certain bioactive peptides such as somatostatin and substance P directly interact with human P-glycoprotein as endogenous substrates for P-glycoprotein-mediated transport. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 35 条
[1]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[2]  
ArchinalMattheis A, 1995, ONCOL RES, V7, P603
[3]  
Chen CP, 1998, J PHARMACOL EXP THER, V287, P545
[4]  
CORNWELL MM, 1986, J BIOL CHEM, V261, P7921
[5]  
DONG J, 1995, ONCOL RES, V7, P245
[6]   MDR1 P-glycoprotein transports endogenous opioid peptides [J].
Elferink, RPJO ;
Zadina, J .
PEPTIDES, 2001, 22 (12) :2015-2020
[7]   EXPRESSION OF A MULTIDRUG-RESISTANCE GENE IN HUMAN-TUMORS AND TISSUES [J].
FOJO, AT ;
UEDA, K ;
SLAMON, DJ ;
POPLACK, DG ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (01) :265-269
[8]   ABSENCE OF COOPERATIVITY FOR MGATP AND VERAPAMIL EFFECTS ON THE ATPASE ACTIVITY OF P-GLYCOPROTEIN CONTAINING MEMBRANE-VESICLES [J].
GARRIGOS, M ;
BELEHRADEK, J ;
MIR, LM ;
ORLOWSKI, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 196 (03) :1034-1041
[9]   MODULATION OF ATP AND DRUG-BINDING BY MONOCLONAL-ANTIBODIES AGAINST P-GLYCOPROTEIN [J].
GEORGES, E ;
ZHANG, JT ;
LING, V .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 148 (03) :479-484
[10]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427